# Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2

> **NCT05596032** · — · COMPLETED · sponsor: **Abionic SA** · enrollment: 440 (actual)

## Conditions studied

- COVID-19
- COVID-19 Pandemic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05596032
- **Lead sponsor:** Abionic SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-23
- **Primary completion:** 2023-01-27
- **Final completion:** 2023-02-01
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05596032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05596032, "Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05596032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
